KVUE

KVUE

USD

Kenvue Inc. Common Stock

$15.970-0.160 (-0.992%)

Prix en Temps Réel

Consumer Defensive
Household & Personal Products
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$16.130

Haut

$16.430

Bas

$15.880

Volume

51.86M

Fondamentaux de l'Entreprise

Capitalisation Boursière

30.6B

Industrie

Household & Personal Products

Pays

United States

Statistiques de Trading

Volume Moyen

33.47M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $14.02Actuel $15.970Haut $25.17

Actualités Connexes

CNBC

Palantir earnings, Pizza Hut's options, a new consumer staples giant and more in Morning Squawk

Here are five key things investors need to know to start the trading day.

Voir plus
Palantir earnings, Pizza Hut's options, a new consumer staples giant and more in Morning Squawk
CNBC

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.

Voir plus
Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'
Reuters

Kenvue’s legal risks loom over planned acquisition by Kimberly-Clark

Kimberly-Clark said on Monday it plans to acquire Band-Aid maker Kenvue , even as the latter company faces thousands of lawsuits involving its painkiller Tylenol and talc-based baby powder, raising questions about the scope of the liabilities Kimberly-Clark might inherit.

Voir plus
Kenvue’s legal risks loom over planned acquisition by Kimberly-Clark
PR Newswire

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

Rowley Law PLLC is investigating potential securities law violations by Kenvue Inc. (NYSE: KVUE) and its board of directors concerning the proposed...

Voir plus
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.
Reuters

Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith

Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's biggest consumer market, the United States, will keep growing even as lower-income shoppers trim their budgets, according to analysts.

Voir plus
Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith
GlobeNewswire

KVUE Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Kenvue to Kimberly-Clark

MONSEY, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Kenvue Inc. (NYSE:KVUE) ("Kenvue") to Kimberly-Clark pursuant to which

Reuters

S&P 500, Nasdaq gain after Amazon-OpenAI deal; Kenvue soars after buyout

The S&P 500 and Nasdaq kicked off November on firmer ground on Monday, after a slew of AI deals boosted megacap companies Amazon and Nvidia, while Kenvue shares soared after Kimberly-Clark's buyout deal.

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.